Evidence map›Paper›PMID 26794445›Full record

ArticleCell death and differentiation2016

MicroRNA-125b regulates microglia activation and motor neuron death in ALS.

C Parisi, G Napoli, S Amadio, A Spalloni, S Apolloni, P Longone, C Volonté

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 2 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 2 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Repositioning of Alogliptin to Mitigate Secondary Injury Induced by Repetitive TBI: Potential Role of its Antioxidant and Anti- Inflammatory Effects.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

C ParisiCNR-Institute of Cell Biology and Neurobiology, Via del Fosso di Fiorano 65, Rome 00143, Italy.
G NapoliSanta Lucia Foundation, Via del Fosso di Fiorano 65, Rome 00143, Italy.
S AmadioCNR-Institute of Cell Biology and Neurobiology, Via del Fosso di Fiorano 65, Rome 00143, Italy.
A SpalloniSanta Lucia Foundation, Via del Fosso di Fiorano 65, Rome 00143, Italy.
S ApolloniCNR-Institute of Cell Biology and Neurobiology, Via del Fosso di Fiorano 65, Rome 00143, Italy.
P LongoneSanta Lucia Foundation, Via del Fosso di Fiorano 65, Rome 00143, Italy.
C VolontéCNR-Institute of Cell Biology and Neurobiology, Via del Fosso di Fiorano 65, Rome 00143, Italy.
Fondazione Santa Lucia · ITInstitute of Cell Biology and Neurobiology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the means by which microglia self-regulate the neuroinflammatory response helps modulating their reaction during neurodegeneration. In amyotrophic lateral sclerosis (ALS), classical NF-κB pathway is related to persistent microglia activation and motor neuron injury; however, mechanisms of negative control of NF-κB activity remain unexplored. One of the major players in the termination of classical NF-κB pathway is the ubiquitin-editing enzyme A20, which has recognized anti-inflammatory functions. Lately, microRNAs are emerging as potent fine-tuners of neuroinflammation and reported to be regulated in ALS, for instance, by purinergic P2X7 receptor activation. In this work, we uncover an interplay between miR-125b and A20 protein in the modulation of classical NF-κB signaling in microglia. In particular, we establish the existence of a pathological circuit in which termination of A20 function by miR-125b strengthens and prolongs the noxious P2X7 receptor-dependent activation of NF-κB in microglia, with deleterious consequences on motor neurons. We prove that, by restoring A20 levels, miR-125b inhibition then sustains motor neuron survival. These results introduce miR-125b as a key mediator of microglia dynamics in ALS.

Indexed as

Amyotrophic Lateral SclerosisAnimalsCell DeathCysteine EndopeptidasesGene ExpressionHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsLipopolysaccharidesMice, Inbred C57BLMicrogliaMicroRNAsMotor NeuronsMutation, MissensePrimary Cell CultureRNA InterferenceCysteine EndopeptidasesIntracellular Signaling Peptides and ProteinsLipopolysaccharidesMicroRNAsMirn125 microRNA, mouseRela protein, mouseSOD1 protein, humanSod1 protein, mouseSuperoxide DismutaseSuperoxide Dismutase-1Tnfaip3 protein, mouseTranscription Factor RelATumor Necrosis Factor alpha-Induced Protein 3

Identifiers

PMID26794445
PMCPMC5072447
OpenAlexW2386536279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.